A cannabis-based formulation developed by Australia's CannPal (ASX:CP1) has substantially reduced atopic dermatitis severity in dogs participating in clinical trial.Atopic dermatitis is triggered by...
Australia's AusCann (ASX: AC8) has announced it has entered into a Heads of Agreement (HoA*) with a major Australian wholesaler of pharmaceutical products.You may...
Augusta University researchers have discovered inhalant cannabidiol (CBD) can effectively hinder the growth of lung cancer in mice, offering new hope in the fight...